Community Outreach and Prevention
November 2019 Vol 10, No 11 | October 25, 2019
More than 80,000 new diagnoses of head and neck cancers are projected in the United States for 2019.
Sharon Lieb Inzetta, RN, MS, CBCN, CN-BN, ONN-CG, Eileen Fleming, MSN, RN, NE-BC, Laura Musarra, BS, MBA
November 2019 Vol 10, No 11 | October 25, 2019
Breast cancer is the second most common cancer after skin cancer and the second leading cause of death of women in the United States after lung cancer.
November 2019 Vol 10, No 11 | October 25, 2019
The National Lung Screening Trial enrolled 53,454 people who were at high risk for lung cancer from August 2002 to April 2004.
November 2019 Vol 10, No 11 | October 25, 2019
Hereditary breast and ovarian cancer syndrome and Lynch syndrome (HBOC/LS) are the 2 most common inherited cancer predisposition syndromes.
November 2018 Vol 9, NO 11 | November 9, 2018
Individuals with hereditary breast and ovarian cancer syndrome (HBOC), caused by mutations in BRCA1 and BRCA2, have some of the highest cancer incidences of any known group.
November 2018 Vol 9, NO 11 | November 9, 2018
Travel and global military presence dictate that international diseases can affect the American populace.
Simon Craddock Lee, PhD, MPH, Heidi A. Hamann, PhD, Magalis Z. Tijerina, BA, Cynthia Ortiz, MPH, Claudia Chavez, MBA, Noel Santini, MD, David E. Gerber, MD
November 2018 Vol 9, NO 11 | November 9, 2018
While adherence to annual screening exceeded 90% in the National Lung Screening Trial, the trial population was disproportionately white, educated, and received care in the tightly controlled environment of a clinical trial.
Stephanie M. Hoopes, BSN, RN, OCN, ONN-CG, Gina Franco, MSN, ANP-C, Jo Weathers, RN, BSN, OCN, CBCN, Pamela Cloys, MSN, ANP-C, LeAnn Perkins, FNP-BC, DipACLM, Mark A O'Rourke, MD, Patricia Leighton, MSN Ed, OCN, ONN-CG
November 2018 Vol 9, NO 11 | November 9, 2018
Lung cancer is the leading cause of cancerrelated death for men and women in the United States.
May 2018 Vol 9, No 5 | May 22, 2018
Federal health officials this week allowed a genetic testing firm to sell kits to consumers to test whether they carry gene mutations that put them at higher risk for breast and ovarian cancer.
Heidi Eve-Cahoon, MSN, RN, CNP, CBCN, Sharon Lieb Inzetta, RN, MS, CBCN, CN-BN, ONN-CG, Melanie Lynch, MD, FACS, Laura Musarra, BS, MBA
November 2017 Vol 8, No 11 | November 14, 2017
Today there are ever-increasing challenges surrounding breast cancer care. The ongoing disparities in delivering cancer care continue to impact our nation as a whole, and, more importantly, for both patients and providers in our local communities.
© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators® PO Box 563, Cranbury, NJ 08512